CAG
34
-2
AXP
74
4
PFG
55
2
MHK
45
2
AON
65
3
NDAQ
77
3
WY
56
2
AEE
55
4
DVA
51
2
FLS
63
2
FOXA
66
2
ZTS
25
4
CMI
75
4
V
54
2
HRL
35
12
MTB
75
2
TAP
37
8
WMT
55
-4
AVGO
35
-19
CVX
28
3
CAG
34
-2
AXP
74
4
PFG
55
2
MHK
45
2
AON
65
3
NDAQ
77
3
WY
56
2
AEE
55
4
DVA
51
2
FLS
63
2
FOXA
66
2
ZTS
25
4
CMI
75
4
V
54
2
HRL
35
12
MTB
75
2
TAP
37
8
WMT
55
-4
AVGO
35
-19
CVX
28
3
Financhill
Back

FolioBeyond Alternative Income and Int Rt Hdg ETF Vs. Zenas BioPharma, Inc. Industry Stock Comparison

Sell
29

RISR
FolioBeyond Alternative Income and Int Rt Hdg ETF

Last Price:
$36.15
Seasonality Move:
5.03%
Buy
60

ZBIO
Zenas BioPharma, Inc.

Last Price:
$42.13
Seasonality Move:
0.59%
Sell
29
FolioBeyond Alternative Income and Int Rt Hdg ETF (RISR) is a Sell

Is FolioBeyond Alternative Income and Int Rt Hdg ETF a Buy, Sell or Hold?

  • The current FolioBeyond Alternative Income and Int Rt Hdg ETF [RISR] share price is $36.18. The Score for RISR is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • RISR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Zenas BioPharma, Inc. (ZBIO) is a Buy

Is Zenas BioPharma, Inc. a Buy, Sell or Hold?

  • The current Zenas BioPharma, Inc. [ZBIO] share price is $42.33. The Score for ZBIO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • ZBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RISR Stock Price Chart

What is FolioBeyond Alternative Income and Int Rt Hdg ETF's stock price today?

  • The FolioBeyond Alternative Income and Int Rt Hdg ETF share price today is $36.18
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RISR is experiencing slight selling pressure.

ZBIO Stock Price Chart

What is Zenas BioPharma, Inc.'s stock price today?

  • The Zenas BioPharma, Inc. share price today is $42.33
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

RISR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.05 Buy
Relative Strength Index (14 RSI): 54.35 Buy
Chaikin Money Flow: -1523 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.92 - 36.24) Buy
Bollinger Bands (100): (35.87 - 36.61) Sell

ZBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.47 Buy
Relative Strength Index (14 RSI): 61.08 Buy
Chaikin Money Flow: 587345 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.32 - 39.82) Buy
Bollinger Bands (100): (17.72 - 34.64) Buy

RISR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.17 Buy
20-day SMA: 36.04 Buy
50-day SMA: 36.01 Buy
200-day SMA: 36.52 Sell
8-day EMA: 22.94 Buy
20-day EMA: 11.94 Buy
50-day EMA: 5.35 Buy
200-day EMA: 1.42 Buy

ZBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.46 Buy
20-day SMA: 37.97 Buy
50-day SMA: 33.51 Buy
200-day SMA: 18.21 Buy
8-day EMA: 24.11 Buy
20-day EMA: 12.41 Buy
50-day EMA: 5.54 Buy
200-day EMA: 1.47 Buy

FolioBeyond Alternative Income and Int Rt Hdg ETF Earnings Growth & RISR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.

FolioBeyond Alternative Income and Int Rt Hdg ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zenas BioPharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):